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THYROTROPHIN AND GROWTH PROMOTING IMMUNOGLOBULIN(TGI) OF 
FRTL - 5 CELLS HAVE NO GROWTH STIMULATING ACTIVITY ON HUMAN 
THYROID EPITHELIAL CELL CULTURES 
B.E. Wenzel, M. Dwenger, T. Mansky, U. Engel*, V. Bay* 
and P.C. S c r i b a 
K l i n i k für Innere Medizin, Med. Universität zu 
Lübeck;D -2400 Lübeck,FRG and * Chirugische K l i n i k , A l l g . 
Krankenhaus, Hamburg-Harburg, FRG 
INTRODUCTION 
When growth promoting a c t i v i t y on t h y r o i d c e l l s was d i s -
covered i n immunoglobulin f r a c t i o n s (TGI) from p a t i e n t s with 
goitrous Graves' disease (GD), an i n t r i g u i n g concept to ex-
p l a i n g o i t r e formation was created ( 1 ) . Indeed, T G I - l i k e 
a c t i v i t y subsequently was described i n p a t i e n t s with non-
t o x i c (NTG) or recur r e n t g o i t r e s ( 2 , 3 > 4 ) » Recently however, 
some doubts were c a s t on t h i s concept for g o i t r e formation, 
s i n c e TGI a c t i v i t y could not be found i n highly p u r i f i e d IgG 
f r a c t i o n s and growth promoting a c t i v i t y i n IgG f r a c t i o n s 
prepared by ammonsulfate p r e c i p i t a t i o n was a t t r i b u t e d to 
contaminations with epidermal growth f a c t o r (EGF) ( 5 ) » More-
over, TGI has not yet been convincingly detected with assay 
systems using human t h y r o i d e p i t h i a l c e l l s (TEC). 
Our own i n t e r e s t to r e a s s e s s TGI a c t i v i t i e s was t r i g g e r e d 
by the i n a b i l i t y to f i n d TGI i n serum from p a t i e n t s with 
euthyroid or recurrent g o i t r e s (not shown). We th e r e f o r e 
i n v e s t i g a t e d the growth promoting a c t i v i t i e s of TGI samples, 
TSH and EGF on human TEC and on r a t FRTL - 5 c e l l s . I n both 
assay systems t r i t r i a t e d thymidin ( HTdR) uptake, g l u c o s e - 6 -
phosphate dehydrogenase (G -6-PD) and adenylcyclase (cAMP) 
were measured. 
METHODS 
TECs were e s t a b l i s h e d from t h y r o i d t i s s u e obtained at 
operation of p a t i e n t s with GD or NTG. After separating TECs 
from debris and erythro c y t e s by density c e n t r i f u g a r i o n c e l l s 
were plated i n Iscove medium supplemented with i n s u l i n , 
t r a n s f e r r i n , hydrocortisone, somastatin, and g l y - h i s - l y s 
t r i p e p t i d e i n 0.5% FCS (5H medium) ( 6 ) . 20 x 1 0 3 c e l l s 1 per 
w e l l of 96 w e l l M i c r o t i t e r f l a t bottom p l a t e s were growing i n 
semi f o l l i c l e - l i k e s t r u c t u r e s (domes) d i s p l a y i n g " r i g h t s i d e 
out" p o l a r i t y . The d i f f e r e n t i a t e d function of TECs i n 
cu l t u r e s was v e r i f i e d by t h e i r a b i l i t y to sec r e t e thyroglo-
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b u l i n and to express microsomal(M) antigen on TSH 
s t i m u l a t i o n . 
The r a t FRTL - 5 c e l l s were grown i n Coon's 5H medium plus 1 
mU bTSH/ml. Before these c e l l s were used f o r TGI assays TSH 
was withdrawn for 5 days. Both TECs and FRTL - 5 c e l l s were 
used for HTdR uptake i n 96 w e l l p l a t e s a f t e r c u l t u r e s 
reached 2 / 3 confluency. The supernatants of c u l t u r e s were 
used for measuring cAMP st i m u l a t i o n ( 7 ) of c e l l s . C e l l c u l -
t u r e s were preincubated for 48 h with IgGs (O.lmg/ml ),TSH 
( l 0 - 1 0 V u / m l ) or EGF ( 0 . 1 - 5 ng/ml) . I n order to measure the 
2 4 h 3HTdR uptake c e l l s were washed, detached from p l a s t i c 
bottoms by t r y p s i n d i g e s t i o n and harvested on c e l l u l o s e ace-
t a t e f i l t e r with a c e l l h a r v e s t e r using 10% t r i - c h l o r - a c e t i c 
a c i d , and 9 6 % cold ethanol. R e s u l t s were c a l c u l a t e d as stimu-
l a t i o n i n d i c e s ( 8 ) . The G-6-PD was measured k i n e t i c a l l y ( 9 ) 
using c e l l s grown and preincubated i n 16 w e l l Costar p l a t e s . 
The G-6-PD a c t i v i t y was expressed as % over c o n t r o l c u l t u r e s . 
Three IgGs from p a t i e n t s with GD were used for the study. 
They were p o s i t i v e f or t h y r o i d s t i m u l a t i n g antibodies (TSab) 
and showed growth promoting a c t i v i t y i n the 3HTdR uptake 
assay of FRTL - 5 c e l l s . As a normal c o n t r o l a pool of IgGs 
from healthy i n d i v i d u a l s of the laboratory s t a f f was used. 
A l l IgGs were prepared from serum by ionexchangechromoto-
graphie on A f f i - G e l - Blue and concentrated by Minicon- u l t r a -
f i l t r a t i o n chambers. A l l IgG samples were adjusted to lmg/ml 
and stored i n l i q u i d nitrogen u n t i l use. 
MATERIALS 
Collagenase (Dispase I I ) was from Boehringer, Mannheim, 
FRG. F e t a l c a l f serum (FCS), Iscove medium and a d d i t i v e s were 
from Biochrom, West B e r l i n . Coon's modified medium was from 
GIBCO, Europe, Karlsruhe, FRG. TSH (Thyrostimulin) was from 
Organon, Munich, FRG. EGF and a l l hormone a d d i t i v e s were from 
Sigma Chemie, Deisenhofen, FRG. T r i t i a t e d thymidin and the 
cAMP binding-protein assay were from NEN, D r e i e i c h , FRG. 
A f f i - G e l - Blue was from BioRad Lab., Munich, FRG. The FRTL - 5 
r a t c e l l s were k i n d l y provided by Dr. L. Kohn, Bethesda, USA. 
RESULTS 
By s t i m u l a t i n g FRTL - 5 r a t c e l l s with TSH ( F i g . l a ) the growth 
promoting a c t i v i t y i s apparently mediated by adeny l c y c l a s e 
a c t i v a t i o n . I n addition, the 3HTdR uptake i s p a r a l l e l e d by 
the a c t i v a t i o n of G-6-PD. Human TECs d i s p l a y a d i f f e r e n t 
p a t t e r n of TSH s t i m u l a t i o n ( F i g . l b ) . Although TSH i s s t i m u l a -
t i n g the adenyl-cyclase, HTdR uptake as w e l l as G-6-PD stay 
f l a t . 
A s i m i l a r r e s u l t i s obtained with IgG preparations from 
GD-patients ( n = 3 ) : With FRTL - 5 c e l l s the 3HTdR uptake i n -
c r e a s e s by 2 . 8 - 5*9 times accompanied by an cAMP i n c r e a s e of 
2 0 0 - 6 0 0 % ( F i g . 2 ) . I n c o n t r a s t , human TECs a f t e r incubation 
with IgGs (GD) do not incorporate s i g n i f i c a n t l y more thymidin 
than c o n t r o l IgGs, although cAMP i n c r e a s e s by 1 2 0 - 4 0 0 % com-
pared to pooled normal IgG.EGF served as a c o n t r o l for the 
p r o l i f e r a t i o n assay with human TECs. Thymidin uptake was 
in c r e a s e d by 2 . 5 - 7 . 1 f o l d ( n = 4 ) , while FRTL - 5 c e l l s of course 
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FIGURE 1. 
Growth and cAMP stimulation by bTSH 
DISCUSSION 
Various experimental assay systems ( 1 , 2 , 3 ? 4 ) using 
t h y r o i d c e l l s from d i f f e r e n t s p e c i e s ( l , 3 > 4 ) have been em-
ployed to demonstrate t h y r o i d growth s t i m u l a t o r s i n IgG pre-
parations from p a t i e n t s with auto-immune and non-immune g o i t -
rous t h y r o i d d i s o r d e r s ( 1 , 2 , 4 ) . Both, the assay systems and 
the o r i g i n of t h y r o i d c e l l s have rather contributed to confu-
sion than to c l a r i f y t h y r o i d c e l l growth i n v i t r o and g o i t r e 
formation i n vivo. This i s p a r t i c u l a r l y t r u e for the human 
th y r o i d , where the mechanisms of p r o l i f e r a t i o n c o n t r o l are 
not yet understood. 
While TSH mediates growth s t i m u l a t i o n through a cAMP 
s i g n a l i n dog and r a t c e l l s ( 1 0 , 1 1 ) , no such e f f e c t i s obser-
ved i n pig and sheep thyroid c e l l s ( 1 2 , 1 3 ) . We here confirm 
that TSH does not induce p r o l i f e r a t i o n i n human TECs, a l -
though i t a c t i v a t e s adenylcyclase ( F i g . l b ) ( 1 4 , 1 5 ? 1 6 ) . I n 
c o n t r a s t , FRTL5 c e l l s stimulated with TSH showed i n c r e a s e d 
cAMP thymidine uptake and G-6-PD a c t i v a t i o n , which i s i n d i r e -
c t l y l i n k e d to DNA-synthesis ( F i g . l a ) ( 1 7 ) . Since i n FRTL - 5 
c e l l s growth i s mediated by adenyl c y c l a s e a c t i v a t i o n , i t 
makes FRTL - 5 c e l l s a dubious t o o l to measure TGI a c t i v i t i e s 
from hyperthyroid GD-patients. C h a r a c t e r i s t i c a l l y , these 
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p a t i e n t s mostly have cAMP s t i m u l a t i n g Tsab. Thus,with TSab 
p o s i t i v e GD-IgGs, the FRTL - 5 c e l l system should always detect 
growth s t i m u l a t i o n . But even the FRTL - 5 c e l l system has been 
reported to detect s e l e c t i v e l y TGI i n IgGs of goitrous GD-
p a t i e n t s ( 3 ) . T h i s might be due to the i n s e n s i t i v i t y of assay 
systems employed. I t does , however, s t i l l allow an adenyl-
c y c l a s e independent growth stimulator a c t i n g on FRTL - 5 c e l l s . 
These growth promoting IgGs derive from humans and sup-
posedly stimulate g o i t r e formation i n vi v o . One should there-
fore assume that these s t i m u l a t o r s would promote growth of 
human TECs i n v i t r o , i f they do r e a c t d i r e c t l y on the thyroid 
c e l l s and i f TECs s t i l l have d i f f e r e n t i a t e d c h a r a c t e r i s t i c s 
i n v i t r o . TECs i n our hands, were almost f r e e of f i b r o b l a s t s 
(5H medium). They displayed M-antigen on TSH and TSab stimu-
l a t i o n and they synthesized t h y r o g l o b u l i n . With our, 
admittedly, small number of IgGs from goitrous, hyperthyroid 
GD-patients, we could not detect growth promoting a c t i v i t y 
( F i g . 2 ) , although the same IgGs stimulated 3HTdR uptake i n 
















p a t i e n t s 
promoting and s t i m u l a t i n g a c t i v i t i e s of IgG from 
(IgG ),IgG from normals(IgG ) and of EGF. 
CZ3-- FRTL - 5 c e l l s E2-
GD-
Human TECs 
The s i t u a t i o n i n euthyroid and r e c u r r e n t g o i t e r s appears 
even more c o n f l i c t i n g , s i n c e growth promoting a c t i v i t y i n IgG 
prepared by ammoniumsulfate p r e c i p i t a t i o n was a t t r i b u t e d to 
EGF contaminations. We were not able so f a r to demonstrate 
s t i m u l a t i o n of c e l l growth with IgGs prepared by ionexchange-
chromatography using the HdR uptake of human TECs. 
In conclusion, future work on growth promoting a c t i v i -
t i e s i n human IgGs , should not only define better the acting 
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agent but al s o the mechanism by which c e l l p r o l i f e r a t i o n i s 
modulated. 
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